内部人交易记录
其他尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the full record of transactions filed by Flanagan W. Michael. Officer active across 1 company, notably Avidity Biosciences, Inc.. Aggregated, 16 disclosures have been logged. Breakdown: 0 buy · 4 sells. Total volume traded: €876k. Activity tracked since 20 January 2023. The latest transaction was filed on 17 December 2025 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Flanagan W. Michael
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报16 总计
27,500 股0Common StockSEC:0001599901-25-000223:0
20,000 股@ US$14.224.7% 占其流量Common StockSEC:0001599901-25-000184:0
20,000 股@ US$14.225.0% 占其流量Common StockSEC:0001599901-25-000113:0
11,780 股@ US$31.05847.2% 占其流量Common StockSEC:0001599901-25-000071:0
20,000 股@ US$14.225.6% 占其流量Common StockSEC:0001599901-25-000063:0
3,860 股@ US$28.59672.3% 占其流量Common StockSEC:0001599901-25-000037:0
25,000 股0Common StockSEC:0001599901-25-000029:0
12,742 股@ US$32.668.5% 占其流量Common StockSEC:0001599901-24-000207:0
24,000 股@ US$22.4710.9% 占其流量Common StockSEC:0001599901-24-000197:0
62,500 股@ US$26.7532.3% 占其流量Common StockSEC:0001599901-24-000166:0
25,000 股0Common StockSEC:0001599901-24-000160:0
62,500 股@ US$26.7532.4% 占其流量Common StockSEC:0001599901-24-000152:0
25,000 股0Common StockSEC:0001599901-24-000108:0
20,000 股0Common StockSEC:0001599901-24-000010:0
4,129 股@ US$10.130.8% 占其流量Common StockSEC:0001599901-24-000010:1
40,000 股0Common StockSEC:0001209191-23-004760:0
About Flanagan W. Michael
Flanagan W. Michael is Chief Scientific Officer at Avidity Biosciences, Inc. He has 13 filings in total, and across the 13 sampled filings from 2023-01-24 to 2025-03-21, sales total EUR 876144 and purchases total EUR 0. The modal transaction nature is Attribution.